TABLE 2.

Phenotypic analysis of cell surface TLR9⁺ cells on ex vivo human PBMC^a

Donor	% Total TLR9+ (R1 gate)	% Isotype control (R1 gate)	% TLR9+ MHC II+ CD19+ (R2 gate)	% TLR9+ MHC II+ CD19− (R2 gate)	% TLR9+ MHC II+ CD11c+ (R2 gate)	% TLR9+ MHC IIlow CD123bright (R2 gate)
1	5.9	1.0	12.5	66.4	NDb	31.9
2	1.0	0.2	13.0	82.9	ND	6.1
3	7.1	0.6	11.2	85.5	ND	3.5
4	8.4	0.7	14.1	72.0	ND	2.4
5	13.3	0.8	2.5	93.4	89.3	2.6
6	4.4	1.0	26.2	64.2	63.3	9.3
7	13.1	0.9	10.8	80.7	82.4	2.7
8	14.8	1.4	2.4	92.1	93.4	2.5
9	19.7	1.2	3.5	83.7	83.4	2.9
10	13.6	1.3	4.9	84.6	87.6	2.5
Avg ± SD	10.1 ± 5.7	0.9 ± 0.4	10.1 ± 7.3	80.6 ± 10.0	83.2 ± 10.6	6.6 ± 9.1

^aPhenotypic analysis is based on flow cytometric analysis data (Fig. 2) obtained from 10 independent donors.

^bND, not done.